Silica sol-gel for the controlled release of antibiotics. II. The effect of synthesis parameters on thein vitro release kinetics of vancomycin
- 5 December 2001
- journal article
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 57 (3) , 321-326
- https://doi.org/10.1002/1097-4636(20011205)57:3<321::aid-jbm1174>3.0.co;2-s
Abstract
Room temperature‐processed silica sol‐gel (xerogel) was investigated as a novel controlled release carrier of vancomycin for the treatment of osteomyelitis. Vancomycin‐loaded xerogels were fabricated with varying water/alkoxysilane molar ratios and vancomycin concentrations. The goal of this study was to determine the effect of varying the aforementioned synthesis parameters on the daily in vitro release kinetics of vancomycin from the xerogel disks. A controlled, load‐dependent, long‐term release of vancomycin was observed for all of the molar ratios that were used in the study (4, 6, and 10). Variations in the water/alkoxysilane molar ratio affected the release process extensively. A cumulative release of about 90% of the original amount of vancomycin was found for molar ratios 6 and 10 by 21 and 14 days, respectively. Only about 30% was released from xerogels with a molar ratio of 4 after 21 days of immersion. A first‐order release stage was followed by a steady release stage for xerogels with molar ratios of 6 and 10, whereas zero‐order release was observed for xerogels with a molar ratio of 4. The findings of this study indicate that the release kinetics of vancomycin from xerogel can be tailored by varying the xerogel synthesis parameters. © 2001 John Wiley & Sons, Inc. J Biomed Mater Res 57: 321–326, 2001Keywords
This publication has 12 references indexed in Scilit:
- Sol–gel derived carrier for the controlled release of proteinsBiomaterials, 1999
- In Vitro Behavior of Silica‐Based Xerogels Intended as Controlled Release CarriersJournal of the American Ceramic Society, 1999
- Pharmacokinetics, uses, and limitations of vancomycin-loaded bone cementInternational Orthopaedics, 1998
- Si-Ca-P xerogels and bone morphogenetic protein act synergistically on rat stromal marrow cell differentiationin vitroJournal of Biomedical Materials Research, 1998
- Treatment of experimental osteomyelitis by surgical debridement and the implantation of bioerodable, polyanhydride‐gentamicin beadsJournal of Orthopaedic Research, 1997
- In vitro release kinetics of biologically active transforming growth factor-β1 from a novel porous glass carrierBiomaterials, 1997
- Treatment of experimental osteomyelitis with antibiotic‐impregnated bone graft substituteJournal of Orthopaedic Research, 1993
- Bioerodible polyanhydrides for antibiotic drug delivery: In vivo osteomyelitis treatment in a rat model systemJournal of Orthopaedic Research, 1993
- Bioerodible polyanhydrides as drug‐carrier matrices. I: Characterization, degradation, and release characteristicsJournal of Biomedical Materials Research, 1985
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963